Lead Product(s) : Tetrahydrocannabinol,Cannabidiol
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : German Pain Association
Deal Size : Undisclosed
Deal Type : Collaboration
German Pain Association and Avextra Join Forces To Launch New Study Ocean
Details : The company aims to focus on the clinical advancement of THC , a partial agonist of the CB1 receptor with Cannabidiol, evaluated for chemotherapy-induced neuropathic pain treatment.
Product Name : THC:CBD
Product Type : Controlled Substance
Upfront Cash : Undisclosed
January 23, 2024
Lead Product(s) : Tetrahydrocannabinol,Cannabidiol
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : German Pain Association
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Induced Pluripotent Stem Cell
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : Bristol Myers Squibb
Deal Size : $6.0 million
Deal Type : Collaboration
Evotec and BMS Expand IPSC Collaboration
Details : This partnership pursues an innovative approach to identifying and creating novel medicines using several of Evotec's technology technologies in tandem with the human iPSC-based platform.
Product Name : Undisclosed
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
July 01, 2020
Lead Product(s) : Induced Pluripotent Stem Cell
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : Bristol Myers Squibb
Deal Size : $6.0 million
Deal Type : Collaboration